Future growth expectations in sales/revenue/volumes?

The company expects sales growth of about 30% to 35% in the next six months compared to the current levels (Page 4). Focus on increasing market share of existing products and creating new business with new products in both domestic and export markets (Page 4). With REACH registrations and increased presence in Europe, export sales in the region are expected to grow significantly over the next two quarters and into next year (Page 9). Plans to grow Core Chemicals acquisition's business in 50 countries where the company already exports, targeting expansion to 100 countries within 2-3 years (Page

Any current/future capex/capital investment/strategic investment?

New plant in Dhule with a planned capex of Rs. 100 crore over four years. First-year investment in Dhule unit to be around Rs. 30 crore. Regular annual capex of Rs. 10 to 20 crore for existing plants focusing on technological improvements and debottlenecking. Capex aimed at increasing production capacity by over 25% with the same manpower through process improvements. Funding for capex planned via 75% bank finance (term loan) and 25% internal accruals. The company intends to maintain a stable debt-to-equity ratio while funding these investments. Strategic acquisition of Core Chemicals to stren

Future growth expectations in earnings/operating earnings/profits/EPS?

EBITDA margins are slowly increasing and expected to improve gradually through focus on specialty products like pharma intermediates and water treatment chemicals, which have higher margins than agrochemicals. Management expects EBITDA margins to improve in the next six months as crude prices stabilize and some cost increases are passed on to customers. Sales growth targeted at 30-35% more than current levels in the next six months, driven by increased market share, new business, and export growth. Capacity utilization currently around 60%, with ongoing capex (Rs 100 crore over 4 years)

Current/ Expected Orderbook/ Pending Orders?

The current order book for Indo Amines Limited is stable, remaining in the range of Rs 125 crore to Rs 130 crore for the next quarter. This figure has been consistent since the last quarter, where it was Rs 125 crore plus. The company anticipates maintaining this order book volume in the near term.

Indo Amines LtdQ2 FY19Chemicals & Petrochemicals

Indo Amines Ltd Q2 FY19 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹119.11P/E: 10.7Market Cap: ₹867 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 2

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

The company expects sales growth of about 30% to 35% in the next six months compared to the current levels (Page 4).
Focus on increasing market share of existing products and creating new business with new products in both domestic and export markets (Page 4).
With REACH registrations and increased presence in Europe, export sales in the region are expected to grow significantly over the next two quarters and into next year (Page 9).
Plans to grow Core Chemicals acquisition's business in 50 countries where the company already exports, targeting expansion to 100 countries within 2-3 years (Page 12).
Emphasis on specialty segments like pharma intermediates and water treatment chemicals, which are expected to drive higher margins and growth (Pages 6 and 11).
Steady Capex driving production enhancement and new capacity, including Rs 100 crore investment over 4 years for a new plant in Dhule (Page 10).

Margin guidance

Category 2

EBITDA margins are slowly increasing and expected to improve gradually through focus on specialty products like pharma intermediates and water treatment chemicals, which have higher margins than agrochemicals.
Management expects EBITDA margins to improve in the next six months as crude prices stabilize and some cost increases are passed on to customers.
Sales growth targeted at 30-35% more than current levels in the next six months, driven by increased market share, new business, and export growth.
Capacity utilization currently around 60%, with ongoing capex (Rs 100 crore over 4 years) aimed at new plant at Dhule and debottlenecking existing plants for increased production by 25%.
Acquisition of Core Chemicals expected to boost revenue and profitability through operational synergies and expanded market reach.
REACH investments are anticipated to increase sales in European markets over the next two quarters to one year.
Overall, profits and EPS are expected to see a steady upward trend supported by margin improvement, enhanced capacities, and growth in new and export markets.

See what Indo Amines Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

- The company plans to fund its upcoming capex primarily through bank financing (term loans). - The planned debt-to-equity ratio for funding the capex is approximately 75:25 (75% bank debt and 25% internal accruals). - Historically, the company has maintained stable bank financing without issues, ensuring repayment capacity. - There is no indication of immediate plans for new equity fundraising mentioned in the transcript. - The company aims to keep the debt-to-equity ratio at levels above 1x but confident of maintaining a manageable ratio. - Debottlenecking and technological improvements will incur smaller capexes funded internally, supporting stable growth. In summary, current and future capex financing will largely rely on debt (bank loans) with internal funds, and no explicit equity fundraising is planned.

See what Indo Amines Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

New plant in Dhule with a planned capex of Rs. 100 crore over four years.
First-year investment in Dhule unit to be around Rs. 30 crore.
Regular annual capex of Rs. 10 to 20 crore for existing plants focusing on technological improvements and debottlenecking.
Capex aimed at increasing production capacity by over 25% with the same manpower through process improvements.
Funding for capex planned via 75% bank finance (term loan) and 25% internal accruals.
The company intends to maintain a stable debt-to-equity ratio while funding these investments.
Strategic acquisition of Core Chemicals to strengthen business, expand export markets, and increase profitability; plans to grow business in 50+ countries and target 100 countries in 2-3 years.

Track Indo Amines Ltd — get its next earnings analysis in your feed

How does Indo Amines Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisIndo Amines Ltd

Rev 2Mar 2

See where Indo Amines Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Indo Amines Ltd rank in Chemicals & Petrochemicals?

Compare Indo Amines Ltd against every Chemicals & Petrochemicals company (Q2 FY19) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Indo Amines Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Indo Amines Ltd Q2 FY19 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Indo Amines Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Indo Amines Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season